View, browse, and sort the education offerings, networking opportunities, and event activities by using the filters below; you can search by Pass Type, Free Content & Activities, and Conference Track. With this session scheduler, you can build your daily agenda in advance and access the full list of options during the event. Sessions do fill up and seating is first come/first serve, so please arrive early to sessions that you would like to attend.
Dr. Kelly McVearry is the CEO of Hypatia Group, Inc., a company that invests in advanced technologies that promote public health, including its subsidiary Hypatia Project, a U.S. Department of Commerce Joint Venture Partner for the development of data technologies and advanced analytics. Kelly serves as Chair of Syndication on the Board of Directors for Life Science Angels in Palo Alto, CA, and she serves as the Chairman of the Board of Directors for Lupus Therapeutics, a subsidiary of the Lupus Research Alliance, in New York, NY. Prior to joining industry, Kelly was a principal investigator and co-investigator for neuroteratology studies of fetal exposure to FDA-approved medications. Training in the laboratory of neurologist Kimford Meador, Kelly obtained a doctorate in Neuroscience with distinction (Georgetown University), a master’s degree in Human Development and Psychology (Harvard University), and a clinical master’s degree in learning disorders and psychoeducational assessment (American University).